Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Screening the Older Population for Atrial Fibrillation—Have We Moved the Needle Forward?

Screening the Older Population for Atrial Fibrillation—Have We Moved the Needle Forward? Opinion EDITORIAL Screening the Older Population for Atrial Fibrillation— Have We Moved the Needle Forward? Roopinder K. Sandhu, MD, MPH; Christine Albert, MD, MPH In this issue of JAMA Cardiology, Gladstone and colleagues care. This randomized assessment demonstrates the efficacy report the results of a multicenter, open-label, randomized of screening a high-risk population using a short-term, non- invasive, continuous monitoring device that reduces the num- clinical trial of screening high-risk older individuals for asymp- tomatic atrial fibrillation (AF). This study investigated a stan- ber-needed-to-screen compared with estimates obtained in a dard care approach of pulse less-enriched population with a single-time point assessment. palpation and auscultation in The results are impressive but not entirely unexpected, given Multimedia the clinic setting (baseline what is known about the prevalence of undetected AF in in- and 6 months) compared with dividuals older than 75 years. Compared with a prior single- Related article page 558 a 2-week continuous electro- arm screening study using an intermittent hand-held moni- cardiographic (cECG) patch tor over 2 weeks, the present study that used noninvasive monitor (baseline and 3 months) in addition to standard care. continuous monitoring was associated with a slightly higher The primary outcome was AF or http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Cardiology American Medical Association

Screening the Older Population for Atrial Fibrillation—Have We Moved the Needle Forward?

JAMA Cardiology , Volume 6 (5) – May 24, 2021

Loading next page...
 
/lp/american-medical-association/screening-the-older-population-for-atrial-fibrillation-have-we-moved-gYPN2oK43w
Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2380-6583
eISSN
2380-6591
DOI
10.1001/jamacardio.2021.0052
Publisher site
See Article on Publisher Site

Abstract

Opinion EDITORIAL Screening the Older Population for Atrial Fibrillation— Have We Moved the Needle Forward? Roopinder K. Sandhu, MD, MPH; Christine Albert, MD, MPH In this issue of JAMA Cardiology, Gladstone and colleagues care. This randomized assessment demonstrates the efficacy report the results of a multicenter, open-label, randomized of screening a high-risk population using a short-term, non- invasive, continuous monitoring device that reduces the num- clinical trial of screening high-risk older individuals for asymp- tomatic atrial fibrillation (AF). This study investigated a stan- ber-needed-to-screen compared with estimates obtained in a dard care approach of pulse less-enriched population with a single-time point assessment. palpation and auscultation in The results are impressive but not entirely unexpected, given Multimedia the clinic setting (baseline what is known about the prevalence of undetected AF in in- and 6 months) compared with dividuals older than 75 years. Compared with a prior single- Related article page 558 a 2-week continuous electro- arm screening study using an intermittent hand-held moni- cardiographic (cECG) patch tor over 2 weeks, the present study that used noninvasive monitor (baseline and 3 months) in addition to standard care. continuous monitoring was associated with a slightly higher The primary outcome was AF or

Journal

JAMA CardiologyAmerican Medical Association

Published: May 24, 2021

References